Louisiana Telemedicine Laws: Permit, Prescribing, Parity

Louisiana gives out-of-state physicians a real front door and then puts a lock on the prescription pad. The Board of Medical Examiners issues a telemedicine permit — a limited license for doctors licensed elsewhere — so cross-border virtual care is legal without full Louisiana licensure. But state law bars prescribing any controlled substance before an in-person history or physical, and the board's rule softens that only to one in-person visit within the past year. On payment, Louisiana has almost no parity mandate at all.

Licensure: the permit is a limited license, not a waiver

The governing premise is in the board's rules: the practice of medicine is deemed to occur at the patient's location, so no physician may deliver telemedicine to a Louisiana patient without an unrestricted Louisiana license or a telemedicine permit. The permit traces to R.S. 40:1223.4(B)(3), which directs every Louisiana licensing board to register out-of-state providers holding an unrestricted, unencumbered license in good standing, comparable to its Louisiana counterpart.

The medical board's version sits at LAC Title 46, Part XLV, §408: ordinary Louisiana licensure qualifications, an unrestricted license from another state, an application fee, annual renewal. The limits sit in §7513, not in the permit rule itself, and they are explicit. A permit holder may not open an office in Louisiana, meet with patients in the state, receive telephone calls in the state from patients, or practice beyond the permit's authority, and supervising an allied health provider in Louisiana requires a full license.

Compacts fill in the rest. Louisiana is a full Interstate Medical Licensure Compact member, effective July 1, 2021 under SB 27, has issued multistate nursing licenses since July 1, 2019, and is a full Physical Therapy Compact member. It is one of only nine states where Counseling Compact privileges are actually being issued, which matters because most member states are not yet live. It has enacted no PSYPACT legislation, so psychologists have no compact route in. Our cross-state licensing tracker has the full map.

Prescribing: the in-person rule that did not go away

R.S. 40:1223.4(B)(5) is permissive on its face — a provider "shall not be required to conduct an in-person patient history or physical examination" before a telehealth encounter — but pairs that with a duty to refer to a Louisiana provider or arrange in-state follow-up as necessary.

Paragraph (B)(6) is the hard line: no provider may prescribe a controlled dangerous substance before an appropriate in-person history or physical examination, except as authorized by R.S. 37:1271.1 or by a licensing board's own rule. The medical board's rule is that exception. Under LAC 46:XLV §7513, a physician may prescribe a controlled substance by telemedicine only after at least one in-person visit within the past year, for a legitimate medical purpose, in conformity with the in-person standard of care. The visit requirement drops away for a Louisiana-licensed physician treating a patient at a state-licensed healthcare facility holding a current DEA registration, and the board may grant individual written exceptions.

The same rule bars telemedicine for treatment of non-cancer-related chronic or intractable pain. It also barred telemedicine treatment of obesity until Act 345 of 2026, effective May 22, 2026, forbade the medical board and the Board of Nursing from prohibiting telehealth evaluation, diagnosis, or treatment of obesity or weight management where the provider conducts a synchronous interaction within scope and standard of care. Neither the board's published rule text nor the consolidated statute has caught up.

Opioid prescribers carry a separate duty. R.S. 40:978(F) requires a prescriber or delegate to review the patient's prescription monitoring program record before initially prescribing any opioid, and at least every ninety days when treatment runs past ninety days. The exceptions are narrower than they look: hospice and terminally ill patients, cancer-related chronic or intractable pain rather than all cancer-related pain, hospitalized patients, a single seven-day supply, and a program outage — and the outage exception is conditional, requiring the prescriber to check the program once access is restored and note the cause of the delay in the chart. One more provision targets this page's core audience. Under R.S. 40:978(E), a Louisiana pharmacist may not dispense more than a ten-day supply of a Schedule II or III opioid derivative written by a prescriber who is not Louisiana-licensed, must cancel the remainder and notify the prescriber, and the drug may not be re-dispensed for that person by a non-Louisiana prescriber for sixty days — unless the prescriber's home-state monitoring data is viewable to the dispensing pharmacist or the prescription carries a cancer or terminal-illness diagnosis.

Our DEA prescribing report tracks the federal layer, currently extended through the end of 2026; verify current status before designing a controlled-substance workflow. Telepsychiatry programs should treat the one-visit-per-year rule as the binding constraint here, not the federal flexibility.

Consent: disclosures more than signatures

Louisiana has no standalone telehealth consent statute; the obligation lives in the board's rules. Section 7511 requires the physician to inform the patient of the physician-patient relationship and the role of any other provider managing care, and to notify the patient that telemedicine may be declined or withdrawn from at any time.

Section 7507 adds a disclosure list, given before the encounter and documented in the record: the physician's name, license number, and contact information; specialty; how to get follow-up and emergency care; how to obtain records; what to do if the technology fails; and a privacy notice. Medicaid's behavioral health policy layers on a fuller informed-consent script covering the rationale for telehealth, risks and benefits including privacy risks, alternatives, and the risks of no treatment.

Medicaid: generous on live video, thin elsewhere

Louisiana Medicaid covers live video broadly. Reimbursement matches the in-person rate, claims carry modifier 95 with the place-of-service code for home or non-home, and the patient's location is unrestricted — home, school, or a facility all qualify. Only the distant-site provider is paid; there is no originating-site facility fee.

Audio-only is allowed for certain services, but the provider must document the need and rationale, and some services require video by clinical necessity. Store-and-forward has no coverage reference in program policy. Remote patient monitoring is covered under the Louisiana Remote Patient Monitoring Program Law; R.S. 40:1227.5 limits it to patients with a provider recommendation who also have a chronic condition, two or more hospitalizations or emergency visits in twelve months, a pregnancy or postpartum status, or an infant discharged from neonatal intensive care. Our remote monitoring guide covers program design.

Private insurance: one narrow provision, and PT and OT

Louisiana's telemedicine insurance provision, R.S. 22:1821(F), was written for a provider-to-provider world. It bars an insurer from denying payment to a licensed physician physically present with the patient at the originating facility while communicating with a physician at the receiving end, and sets that physician's payment at no less than seventy-five percent of the customary amount for an intermediate office visit. Policy language discriminating against or prohibiting telehealth is void as against public policy.

What is missing is a general mandate. The telehealth subpart at R.S. 22:1841 through 1844 defines telehealth, requires issuers to post a telehealth services statement, and sets remote monitoring standards — but does not require plans to cover a direct-to-patient telehealth visit or to pay for one at the in-person rate. The exceptions are service-specific: R.S. 22:1845.1 and 22:1845.2 make coverage and payment for physical and occupational therapy by telehealth equivalent to in-person, unless plan and provider agree on another rate. Model commercial revenue from your contracts, as our reimbursement guide explains.

What to watch

Three items. Act 476 of 2026 requires the Louisiana Department of Health to submit a state plan amendment or waiver to CMS by October 1, 2026 seeking reimbursement for psychosocial rehabilitation delivered by telehealth. The medical board's telemedicine rules are overdue for revision — the published text still carries the obesity prohibition that Act 345 overrode and still cites a licensure statute repealed effective January 1, 2024. And the federal layer, DEA prescribing and Medicare telehealth, sets what the permit route is actually worth; verify current status. Verify current requirements with the Louisiana State Board of Medical Examiners and the Louisiana Department of Health before acting, and compare Louisiana with its neighbors in the national overview.